1. Açık Erişim@BUU
  2. İndeksli Yayınlar
  3. Web of Science
Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/22633
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYalçın, Şuayib-
dc.date.accessioned2021-11-12T10:12:12Z-
dc.date.available2021-11-12T10:12:12Z-
dc.date.issued1999-09-15-
dc.identifier.citationOrhan, B. ve Yalçın, Ş. (1999). "What are cancer patients willing to pay for prophylactic epoetin alfa? A cost-benefit analysis". Cancer, 86(6), 1095-1096.en_US
dc.identifier.issn0008-543X-
dc.identifier.issn1097-0142-
dc.identifier.urihttps://doi.org/10.1002/(SICI)1097-0142(19990915)86:6<1095::AID-CNCR28>3.0.CO;2-K-
dc.identifier.urihttps://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-0142(19990915)86:6%3C1095::AID-CNCR28%3E3.0.CO;2-K-
dc.identifier.urihttp://hdl.handle.net/11452/22633-
dc.language.isoenen_US
dc.publisherWileyen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr_TR
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectOncologyen_US
dc.subjectRecombinant-human-erythropoietinen_US
dc.subjectChronic anemiaen_US
dc.subjectChemotherapyen_US
dc.subjectNeuronsen_US
dc.titleWhat are cancer patients willing to pay for prophylactic epoetin alfa? A cost-benefit analysisen_US
dc.typeLetteren_US
dc.identifier.wos000082582900028tr_TR
dc.identifier.scopus2-s2.0-0033568682tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı.tr_TR
dc.identifier.startpage1095tr_TR
dc.identifier.endpage1096tr_TR
dc.identifier.volume86tr_TR
dc.identifier.issue6tr_TR
dc.relation.journalCanceren_US
dc.contributor.buuauthorOrhan, Bülent-
dc.relation.collaborationYurt içitr_TR
dc.identifier.pubmed10491539tr_TR
dc.subject.wosOncologyen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.contributor.scopusid6701877552tr_TR
dc.contributor.scopusid7101652066tr_TR
dc.subject.scopusPeripheral Nervous System Diseases; Oxaliplatin; Goshajinkiganen_US
dc.subject.emtreeCisplatinen_US
dc.subject.emtreeCytotoxic agenten_US
dc.subject.emtreeRecombinant erythropoietinen_US
dc.subject.emtreeAnemiaen_US
dc.subject.emtreeCanceren_US
dc.subject.emtreeCancer patienten_US
dc.subject.emtreeCost benefit analysisen_US
dc.subject.emtreeDrug costen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHypertensionen_US
dc.subject.emtreeLetteren_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeProphylaxisen_US
dc.subject.emtreeThrombosisen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
File Description SizeFormat 
Orhan_ve_Yalçın_1999.pdf33.02 kBAdobe PDFThumbnail
View/Open
Show simple item record


This item is licensed under a Creative Commons License Creative Commons